Effects of 1,25-Dihydroxy vitamin d3 on endometriosis

Journal of Clinical Endocrinology and Metabolism

Volumn 101, Issue 6, 2016, Pages 2371-2379

  Miyashita, Mariko ^a   Koga, Kaori ^a   Izumi, Gentaro ^a   Sue, Fusako ^a   Makabe, Tomoko ^a   Taguchi, Ayumi ^a   Nagai, Miwako ^a   Urata, Yoko ^a   Takamura, Masashi ^a   Harada, Miyuki ^a   Hirata, Tetsuya ^a   Hirota, Yasushi ^a   Wada Hiraike, Osamu ^a   Fujii, Tomoyuki ^a   Osuga, Yutaka ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; CALCITRIOL; I KAPPA B ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 8; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; CYCLOOXYGENASE 2; GELATINASE A; GELATINASE B; PROSTAGLANDIN E SYNTHASE; PTGES PROTEIN, HUMAN; VITAMIN D;

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE GENE; ADULT; ANTIINFLAMMATORY ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL COUNTING; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYCLOOXYGENASE 2 GENE; CYTOKINE PRODUCTION; CYTOSOLIC PROSTAGLANDIN E SYNTHASE GENE; DISEASE SEVERITY; DNA SYNTHESIS; DRUG BLOOD LEVEL; ENDOMETRIOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; IL 8 GENE; IN VITRO STUDY; MICROSOMAL PROSTAGLANDIN E SYNTHASE 1 GENE; MICROSOMAL PROSTAGLANDIN E SYNTHASE 2 GENE; MMP 2 GENE; MMP 9 GENE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; VITAMIN BLOOD LEVEL; WESTERN BLOTTING; BLOOD; CELL CULTURE; CELL PROLIFERATION; DRUG EFFECTS; ENDOMETRIUM; GENETICS; METABOLISM; OVARY DISEASE; PATHOLOGY;

ADULT; APOPTOSIS; CALCITRIOL; CELL PROLIFERATION; CELLS, CULTURED; CYCLOOXYGENASE 2; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; GENE EXPRESSION; HUMANS; INTERLEUKIN-8; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; OVARIAN DISEASES; PROSTAGLANDIN-E SYNTHASES; STROMAL CELLS; VITAMIN D;

EID: 84973548078     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2016-1515     Document Type: Article

References (44)

1. Giudice LC, Kao LC. Endometriosis. Lancet. 2004;364:1789- 1799.
2. Vercellini P, Vigano P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10:261- 275.
3. Bouillon R, Carmeliet G, Verlinden L, et al. VitaminDand human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008;29:726 -776.
4. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266- 281.
5. Ferreira GB, Vanherwegen AS, Eelen G, et al. Vitamin D3 induces tolerance in human dendritic cells by activation of intracellular metabolic pathways. Cell Rep. In press.
6. Wahono CS, Rusmini H, Soelistyoningsih D, et al. Effects of 1, 25(OH)2D3 in immune response regulation of systemic lupus erythematosus (SLE) patient with hypovitamin D. Int J Clin Exp Med. 2014;7:22-31.
7. Riek AE, OH J, Darwech I, Moynihan CE, Bruchas RR, Bernal- Mizrachi C. 25(OH) vitamin D suppresses macrophage adhesion and migration by downregulation of ER stress and scavenger receptor A1 in type 2 diabetes. J Steroid Biochem Mol Biol. 2014;144(Pt A):172-179.
8. Zhang Y, Leung DY, Richers BN, et al. Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol. 2012;188:2127-2135.
9. Khoo AL, Joosten I, Michels M, et al. 1, 25-Dihydroxyvitamin D3 inhibits proliferation but not the suppressive function of regulatory Tcells in the absence of antigen-presenting cells. Immunology. 2011; 134:459-468.
10. Zhong H, Zhou XJ, Hong JG. The effects of vitamin D on allergeninduced expression of interleukin-13 and interleukin-17 in cord blood CD4(+)T cells. Iran J Allergy Asthma Immunol. 2014;13: 93-97.
11. van Hamburg JP, Asmawidjaja PS, Davelaar N, et al. TNF blockade requires 1, 25(OH)2D3 to control human Th17-mediated synovial inflammation. Ann Rheum Dis. 2012;71:606-612.
12. Karthaus N, van Spriel AB, Looman MW, et al. Vitamin D controls murine and human plasmacytoid dendritic cell function. J Invest Dermatol. 2014;134(5):1255-1264.
13. Krishnan AV, Swami S, Peng L, Wang J, Moreno J, Feldman D. Tissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapy. Endocrinology. 2010;151: 32-42.
14. Mariani M, Vigano P, Gentilini D, et al. The selective vitamin D receptor agonist, elocalcitol, reduces endometriosis development in a mouse model by inhibiting peritoneal inflammation.HumReprod. 2012;27:2010-2019.
15. Urata Y, Koga K, Hirota Y, et al. IL-1β increases expression of tryptophan 2, 3-dioxygenase and stimulates tryptophan catabolism in endometrioma stromal cells. Am J Reprod Immunol. 2014;72: 496-503.
16. Yoshino O, Izumi G, Shi J, et al. Activin-A is induced by interleukin- 1β and tumor necrosis factor-α and enhances the mRNA expression of interleukin-6 and protease-activated receptor-2 and proliferation of stromal cells from endometrioma. Fertil Steril. 2011; 96:118-121.
17. Yoshino O, Osuga Y, Hirota Y, et al. Possible pathophysiological roles of mitogen-activated protein kinases (MAPKs) in endometriosis. Am J Reprod Immunol. 2004;52:306-311.
18. Wu MH, Wang CA, Lin CC, Chen LC, Chang WC, Tsai SJ. Distinct regulation of cyclooxygenase-2 by interleukin-1β in normal and endometriotic stromal cells. J Clin Endocrinol Metab. 2005;90: 286-295.
19. Diaz L, Noyola-Martinez N, Barrera D, et al. Calcitriol inhibits TNF-α-induced inflammatory cytokines in human trophoblasts. J Reprod Immunol. 2009;81:17-24.
20. Noyola-Martinez N, Diaz L, Avila E, Halhali A, Larrea F, Barrera D. Calcitriol downregulates TNF-α and IL-6 expression in cultured placental cells from preeclamptic women. Cytokine. 2013;61: 245-250.
21. Evans KN, Nguyen L, Chan J, et al. Effects of 25-hydroxyvitaminD3 and 1, 25-dihydroxyvitamin D3 on cytokine production by human decidual cells. Biol Reprod. 2006;75:816-822.
22. Thota C, Farmer T, Garfield RE, Menon R, Al-Hendy A. Vitamin Delicits anti-inflammatory response, inhibits contractile-associated proteins, and modulates Toll-like receptors in human myometrial cells. Reprod Sci. 2013;20:463-475.
23. Moreno J, Krishnan AV, Swami S, Nonn L, Peehl DM, Feldman D. Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells. Cancer Res. 2005;65: 7917-7925.
24. Liu X, Nelson A, Wang X, et al. Vitamin d modulates prostaglandin e2 synthesis and degradation in human lung fibroblasts.AmJ Respir Cell Mol Biol. 2014;50:40-50.
25. Noble LS, Takayama K, Zeitoun KM, et al. Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells. J Clin Endocrinol Metab. 1997;82:600-606.
26. Munetsuna E, Kawanami R, Nishikawa M, et al. Anti-proliferative activity of 25-hydroxyvitamin D3 in human prostate cells. Mol Cell Endocrinol. 2014;382:960-970.
27. Nishida M, Nasu K, Ueda T, Fukuda J, Takai N, Miyakawa I. Endometriotic cells are resistant to interferon-γ-induced cell growth inhibition and apoptosis: A possible mechanism involved in the pathogenesis of endometriosis. Mol Hum Reprod. 2005;11:29-34.
28. Nguyen H, Ivanova VS, Kavandi L, Rodriguez GC, Maxwell GL, Syed V. Progesterone and 1, 25-dihydroxyvitamin D(3) inhibit endometrial cancer cell growth by upregulating semaphorin 3B and semaphorin 3F. Mol Cancer Res. 2011;9:1479-1492.
29. Halder SK, Osteen KG, Al-Hendy A. VitaminD3inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells. Hum Reprod. 2013;28:2407-2416.
30. Singh AK, Chattopadhyay R, Chakravarty B, Chaudhury K. Altered circulating levels of matrix metalloproteinases 2 and 9 and their inhibitors and effect of progesterone supplementation in women with endometriosis undergoing in vitro fertilization. Fertil Steril. 2013;100:127-134.e121.
31. Yildirim B, Guler T, Akbulut M, Oztekin O, Sariiz G. 1-α, 25-dihydroxyvitamin D3 regresses endometriotic implants in rats by inhibiting neovascularization and altering regulation of matrix metalloproteinase. Postgrad Med. 2014;126:104-110.
32. Lappas M. NOD1 and NOD2 regulate proinflammatory and prolabor mediators in human fetal membranes and myometrium via nuclear factor-κB. Biol Reprod. 2013;89:14.
33. Tobar N, Villar V, Santibanez JF. ROS-NFκB mediates TGF-β1- induced expression of urokinase-type plasminogen activator, matrix metalloproteinase-9 and cell invasion. Mol Cell Biochem. 2010; 340:195-202.
34. Lundqvist J, Yde CW, Lykkesfeldt AE. 1α, 25-DihydroxyvitaminD3 inhibits cell growth and NFκB signaling in tamoxifen-resistant breast cancer cells. Steroids. 2014;85:30-35.
35. Thota C, Laknaur A, Farmer T, Ladson G, Al-Hendy A, Ismail N. VitaminDregulates contractile profile in human uterine myometrial cells via NF-κB pathway. Am J Obstet Gynecol. 2014;210(4): 347.e1-347.e10.
36. Stio M, Martinesi M, Bruni S, et al. The VitaminDanalogueTX527 blocks NF-κB activation in peripheral blood mononuclear cells of patients with Crohn's disease. J Steroid Biochem Mol Biol. 2007; 103:51-60.
37. Mutt SJ, Karhu T, Lehtonen S, et al. Inhibition of cytokine secretion from adipocytes by 1, 25-dihydroxyvitamin D(3) via the NF-κB pathway. FASEB j. 2012;26:4400-4407.
38. Harris HR, Chavarro JE, Malspeis S, Willett WC, Missmer SA. Dairy-food, calcium, magnesium, and vitamin D intake and endometriosis: A prospective cohort study. Am J Epidemiol. 2013;177: 420-430.
39. Somigliana E, Panina-Bordignon P, Murone S, Di Lucia P, Vercellini P, Vigano P. Vitamin D reserve is higher in women with endometriosis. Hum Reprod. 2007;22:2273-2278.
40. Agic A, Xu H, Altgassen C, et al. Relative expression of 1, 25-dihydroxyvitamin D3 receptor, vitamin D 1α-hydroxylase, vitamin D 24-hydroxylase, and vitamin D 25-hydroxylase in endometriosis and gynecologic cancers. Reprod Sci. 2007;14:486-497.
41. Hartwell D, Rodbro P, Jensen SB, Thomsen K, Christiansen C. Vitamin D metabolites-relation to age, menopause and endometriosis. Scand J Clin Lab Invest. 1990;50:115-121.
42. Maeda SS, Saraiva GL, Hayashi LF, et al. Seasonal variation in the serum 25-hydroxyvitamin D levels of young and elderly active and inactive adults in Sao Paulo, Brazil: The Sao PAulo Vitamin D Evaluation Study (SPADES). Dermatoendocrinology. 2013;5:211-217.
43. Kennedy DA, Cooley K, Skidmore B, Fritz H, Campbell T, Seely D. Vitamin d: pharmacokinetics and safety when used in conjunction with the pharmaceutical drugs used in cancer patients: A systematic review. Cancers (Basel). 2013;5:255-280.
44. Yang L, Weaver V, Smith JP, Bingaman S, Hartman TJ, Cantorna MT. Therapeutic effect of vitamin D supplementation in a pilot study of Crohn's patients. Clin Transl Gastroenterol. 2013;4:e33.